Skip to content
buyModerate cluster of 2

Cheryl Xu bought $75k of SXTP

director at 60 DEGREES PHARMACEUTICALS, INC.. 200,000 shares at an average of $0.38, traded Jan 31, 2024, filed Feb 2, 2024.

Conviction score
59
Value
$75k
200,000 shares
Holdings after
424,934
+89% from before
From 52-week low
0%
low $67.20, close $67.20
From 52-week high
-94%
high $1,123.20, as of Jan 31, 2024

Score components

  • Role
    Director
    +15
  • Trade size
    $75k at market
    +8
  • Relative to holdings
    Holdings up 89%
    +10
  • Price context
    0% above the 52-week low; 94% below the 52-week high
    +18
  • Cluster
    2 insiders buying within 14 days
    +8
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (2 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

SXTPOct 13, 2026 · close 0.90
Since filing Feb 2, 2024: -98.7%SPY +62.5% · excess -161.2%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001213900-24-009599, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jan 31, 2024POpen-market purchase
Common Stock
+200,000$0.38$75k424,934Feb 2, 2024
Feb 1, 2024MOption exercise
Common Stock
+2,000--6,000Feb 2, 2024
Jan 31, 2024POpen-market purchase
Warrantderivative
+200,000$0.01$2,000200,000Feb 2, 2024

Related signals

Other insiders at 60 DEGREES PHARMACEUTICALS, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
49Moderate
SXTPbuy
60 DEGREES PHARMACEUTICALS, INC.
Geoffrey S Dow
President and CEO
$10k
7,350 shares
+44%
51Moderate
SXTPbuy
60 DEGREES PHARMACEUTICALS, INC.
Geoffrey S Dow
President and CEO
$7,759
9,670 shares
+19%
49Moderate
SXTPbuy
60 DEGREES PHARMACEUTICALS, INC.
Geoffrey S Dow
President and CEO
$12k
12,963 shares
+35%
29Weak
SXTPbuy
60 DEGREES PHARMACEUTICALS, INC.
Cheryl Xu
director
$14k
5,000 shares
+46%
29Weak
SXTPbuy 2
60 DEGREES PHARMACEUTICALS, INC.
Cheryl Xu
director
$21k
13,000 shares
+32%
57Moderate
SXTPbuy 2
60 DEGREES PHARMACEUTICALS, INC.
Geoffrey S Dow
President and CEO
$90k
73,951 shares
+358%
35Weak
SXTPbuy
60 DEGREES PHARMACEUTICALS, INC.
Geoffrey S Dow
President and CEO
$6,367
7,000 shares
+51%
26Weak
SXTPbuy
60 DEGREES PHARMACEUTICALS, INC.
Cheryl Xu
director
$8,500
5,000 shares
+14%
51Moderate
SXTPbuy 2
60 DEGREES PHARMACEUTICALS, INC.
Geoffrey S Dow
President and CEO
$9,740
25,974 shares
+4%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Cheryl Xu bought $75k of SXTP | InsiderTell